Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial

Lignende værker

• Beta Agonist Lung Injury TrIal-2 (BALTI-2) trial protocol: A randomised, double-blind, placebo-controlled of intravenous infusion of salbutamol in the acute respiratory distress syndrome
  af: Perkins, Gavin D, et al.
  Udgivet: (2011)
• Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome
  af: S Gates, et al.
  Udgivet: (2013-09-01)
• Beta-Agonist Lung injury TrIal-2 (BALTI-2): a multicentre, randomised, double-blind, placebo-controlled trial and economic evaluation of intravenous infusion of salbutamol versus placebo in patients with acute respiratory distress syndrome.
  af: Gates, S, et al.
  Udgivet: (2013)
• Bench-to-bedside review: β(2)-Agonists and the acute respiratory distress syndrome
  af: Perkins, Gavin D, et al.
  Udgivet: (2004)
• Reply: Importance of the Kidney, Vessels, and Heart with Administration of β(2) Adrenergic Receptor Agonists in Patients Susceptible to Acute Respiratory Distress Syndrome
  af:  Thickett, David R., et al.
  Udgivet: (2014)